Effect of dl-praeruptorin A on desmin and vimentin content in rat ischemia/reperfusion myocardiocytes

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2256-2259

  Chang, He ^a   Chu, Xiao Yu ^b   Zou, Jun ^c   Chang, Tian Hui ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c XIAMEN UNIVERSITY   (China)

Author keywords

Desmin; dl Praeruptorin A; Intermediate filament; Ischemia; Myocardiocyte; Vimentin

Indexed keywords

DESMIN; EOSIN; HEMATOXYLIN; HERBACEOUS AGENT; NIFEDIPINE; PLACEBO; PRAERUPTORIN A; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DENSITOMETRY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; FEMALE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN CONTENT; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 38349146715     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00019     Document Type: Article

References (10)

1. Oshima RG. Intermediate filaments: a historical perspective. Exp Cell Res 2007; 313: 1981-1994.
2. Carlsson L, Thornell LE. Desmin-related myopathies in mice and man. Acta Physiol Scand 2001; 171: 341-348.
3. Schnittler HJ, Schmandra T, Drenckhahn D. Correlation of endothelial vimentin content with hemodynamic parameters. Histochem Cell Biol 1998; 110: 161-167.
4. Chang TH, Liu XY, Zhang XH, Wang HL. Effects of dl-praeruptorin A on interleukin-6 level and Fas, bax, bcl-2 protein expression in ischemia-reperfusion myocardium. Acta Pharmacol Sin 2002; 23: 769-774.
5. Wang C, Chang TH, Zhang XH, Wang HL. Effects of dl-praeruptorin A on nucleus factor-κB and tumor necrosis factor-α expression in ischemia-reperfusion hearts. Acta Pharmacol Sin 2004; 25: 35-40.
6. Wang C, Chang TH. Comparative research between Bai-hua Qian-hu, a Chinese traditional plant, and its active ingredient on nuclear factor-κB and tumor necrosis factor-α in isolated ischemia-reperfusion heart of rat. Chin Med J 2004; 117: 461-463.
7. Di Somma S, Di Benedetto MP, Salvatore G, Agozzino L, Ferranti F, Esposito S, et al. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure. Eur J Heart Fail 2004; 6: 389-398.
8. Costa ML, Escaleira R, Cataldo A, Oliveira F, Mermelstein CS. Desmin: molecular interactions and putative functions of the muscle intermediate filament protein. Braz J Med Biol Res 2004; 37: 1819-1830.
9. Sampayo-Reyes A, Narro-Juarez A, Said-Fernandez S, Lozano-Garza HG, Vargas-Villarreal J, Mata-Cardenas BD, et al. Effect of clofibric acid on desmin and vimentin contents in rat myocardiocytes. Int J Toxicol 2006; 25: 403-408.
10. 2+-activated cytoskeleton protein degradation. Cardiovasc Res 2000; 45: 810-812.